Dermatological side-effects in hepatitis C infected patients under a triple regimen associating pegylated interferon, ribavirin and telaprevir
| Autor: | Stanislas Pol, Nicolas Ortonne, Christophe Hézode, J.-C. Duclos-Vallée, Didier Samuel, Vincent Mallet, L. Gressier, Nicolas Dupin, N. Wallet-Faber, Laurence Valeyrie-Allanore, B. Milpied, Philippe Bernard, C. Bernardeschi |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Male
medicine.medical_specialty Biopsy Dermatology Antiviral Agents Gastroenterology Telaprevir 030207 dermatology & venereal diseases 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Risk Factors Pegylated interferon Internal medicine Ribavirin medicine Humans Prospective Studies 030212 general & internal medicine Aged business.industry Hepatitis C Middle Aged medicine.disease Regimen Infectious Diseases chemistry Female Drug Eruptions Interferons business Oligopeptides medicine.drug |
| Zdroj: | Journal of the European Academy of Dermatology and Venereology. 30:143-146 |
| ISSN: | 0926-9959 |
| DOI: | 10.1111/jdv.12635 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text